tm logo
BRIGHTGENE
Live/Registered
REGISTERED

on 31 Aug 2021

Last Applicant/ Owned by

BioBay, Suzhou Industrial Park, Suzhou

CN

Serial Number

79278137 filed on 28th Oct 2019

Registration Number

6465606 registered on 31st Aug 2021

in the Principal Register

Correspondent Address

Eric Lamb

Eric Lamb

201 North Illinois Street, Suite 1900

Frost Brown Todd LLC, IN 46204

Filing Basis

No Filing Basis

Disclaimer

NO DATA

BRIGHTGENE

Injectable solutions for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; prepared Chinese medicine for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficie Read More

Classification Information


Class [005]
Pharmaceutical Products


Injectable solutions for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; prepared Chinese medicine for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; chemical pharmaceutical preparations for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; medicinal preparations for the mouth in the form of tablets or compressed tablets for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; medicines for human purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; biochemical medical drug for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; pharmaceutical preparations for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; chemical preparations for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; drugs for medical purposes for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders; active pharmaceutical ingredients for treatment of cardiovascular diseases, cerebrovascular diseases, viral infection, tumors, fungal infections, bacterial infection, iron-deficiency disease, and immune system disorders

Mark Details


Serial Number

No 79278137

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th Feb 2022FINAL DECISION TRANSACTION PROCESSED BY IB
07th Feb 2022FINAL DISPOSITION NOTICE SENT TO IB
07th Feb 2022FINAL DISPOSITION PROCESSED
30th Nov 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
31st Aug 2021REGISTERED-PRINCIPAL REGISTER
24th Jul 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07th Jul 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07th Jul 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
15th Jun 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Jun 2021PUBLISHED FOR OPPOSITION